Athersys and Chugai partner on stem cell therapy for stroke – BioPharma-Reporter.com
BioPharma-Reporter.com |
Athersys and Chugai partner on stem cell therapy for stroke
BioPharma-Reporter.com Multistem is a therapy product derived from human stem cells that can promote tissue repair and healing. Once the cells are obtained they are expanded, tested for function and subsequently frozen. The frozen cells can be shipped to a physician's … |
